ECM
BMY icon

ETrade Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

ETrade Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$4.33M Sell
71,780
-6,634
-8% -$399K 0.08% 128
2020
Q2 		$4.61M Buy
78,414
+10,225
+15% +$612K 0.1% 107
2020
Q1 		$3.8M Sell
68,189
-3,115
-4% -$190K 0.1% 107
2019
Q4 		$4.58M Buy
71,304
+6,697
+10% +$384K 0.1% 111
2019
Q3 		$3.28M Buy
64,607
+4,317
+7% +$203K 0.08% 147
2019
Q2 		$2.73M Sell
60,290
-4,377
-7% -$204K 0.07% 163
2019
Q1 		$3.08M Buy
64,667
+9,354
+17% +$466K 0.09% 135
2018
Q4 		$2.88M Sell
55,313
-3,777
-6% -$203K 0.09% 122
2018
Q3 		$3.67M Buy
59,090
+15,020
+34% +$891K 0.11% 107
2018
Q2 		$2.44M Sell
44,070
-4,196
-9% -$227K 0.08% 151
2018
Q1 		$3.05M Buy
48,266
+973
+2% +$62.6K 0.1% 112
2017
Q4 		$2.9M Buy
47,293
+7,712
+19% +$482K 0.09% 122
2017
Q3 		$2.52M Buy
39,581
+3,051
+8% +$178K 0.09% 130
2017
Q2 		$2.04M Buy
36,530
+13,056
+56% +$710K 0.08% 153
2017
Q1 		$1.28M Buy
23,474
+7,161
+44% +$393K 0.05% 200
2016
Q4 		$953K Sell
16,313
-1,002
-6% -$54.8K 0.04% 250
2016
Q3 		$934K Buy
17,315
+579
+3% +$37.2K 0.05% 238
2016
Q2 		$1.23M Buy
16,736
+8,981
+116% +$635K 0.07% 174
2016
Q1 		$495K Buy
7,755
+3,129
+68% +$197K 0.03% 331
2015
Q4 		$318K Buy
+4,626
New +$306K 0.02% 369
2014
Q2 		– Sell
-1,389
Closed -$72K – 460
2014
Q1 		$72K Sell
1,389
-1,572
-53% -$83.6K 0.01% 532
2013
Q4 		$157K Sell
2,961
-38
-1% -$1.94K 0.01% 310
2013
Q3 		$139K Sell
2,999
-427
-12% -$18.7K 0.01% 303
2013
Q2 		$153K Buy
+3,426
New +$149K 0.02% 269

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

ETrade Capital Management's BMY Position: Q3 2020 in Review

ETrade Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 8.5% in Q3 2020, selling an estimated $399K and leaving 71,780 shares worth $4.33M. The position accounts for 0.08% of the portfolio, ranked #128.

ETrade Capital Management first reported a position in BMY in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.61M in Q2 2020. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • ETrade Capital Management held 71,780 shares of Bristol-Myers Squibb worth $4.33M as of Q3 2020.
  • ETrade Capital Management sold 6,634 Bristol-Myers Squibb shares in Q3 2020, an estimated $399K.
  • Bristol-Myers Squibb made up 0.08% of ETrade Capital Management's portfolio in Q3 2020, its #128 holding.
  • ETrade Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 24 quarters since.
  • ETrade Capital Management's Bristol-Myers Squibb position peaked at $4.61M in Q2 2020.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.